Blanco M, Villar A
Departament de Química, Unitat de Química Analítica, Facultat de Ciències, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain.
Analyst. 2000 Dec;125(12):2311-4. doi: 10.1039/b005746k.
A method for the characterization and determination of the crystalline from present in the amorphous miokamycin of a pharmaceutical preparation using near-infrared spectroscopy (NIRS) is proposed. The study leading to the development of the proposed method involved both qualitative (classification by residual variance analysis) and quantitative aspects (the determination of both total miokamycin and its crystalline form using multivariate calibration). Samples containing less than 5% of the total amount of miokamycin in its crystalline form can be accurately classified. Partial least-squares regression (PLSR) allows low contents of the crystalline form to be determined with absolute errors less than 1.5%, which is comparable to the limit of detection of the X-ray diffraction technique used as reference. Also, the total miokamycin content is determined by NIRS with errors less than 1%. The simplicity, expeditiousness and robustness of the proposed method make it an effective tool for determining both total and crystalline miokamycin in solid dosage forms.
提出了一种使用近红外光谱法(NIRS)表征和测定药物制剂中非晶型米卡霉素中结晶型米卡霉素的方法。导致该方法开发的研究涉及定性(通过残差方差分析进行分类)和定量方面(使用多元校准测定总米卡霉素及其结晶形式)。含有结晶形式米卡霉素总量少于5%的样品可以被准确分类。偏最小二乘回归(PLSR)能够测定低含量的结晶形式,绝对误差小于1.5%,这与用作参考的X射线衍射技术的检测限相当。此外,通过近红外光谱法测定的总米卡霉素含量误差小于1%。所提出方法的简单性、快速性和稳健性使其成为测定固体剂型中总米卡霉素和结晶型米卡霉素的有效工具。